June 21, 2010 - June 22, 2010

Helmsley Park Lane
New York, NY

American Conference Institute
CustomerService@AmericanConference.com
888-224-2480

Thomas J. Filarski and K. Shannon Mrksich, Ph.D., shareholders with Brinks Hofer Gilson & Lione, will be speaking at American Conference Institute's Follow-On Biologics. The conference will be held in New York City on June 21-22. Mr. Filarski, Chair of the Chemical Group at Brinks, will be participating in a discussion titled "An Overview of Dispute Resolution Mechanisms Under PHS §351." Dr. Mrksich, Chair of the Biotechnology and Pharmaceutical Group at Brinks, will be participating in a discussion titled "Maximizing the Biologic Patent Lifecycle and Protecting the Value of IP for Biologics in Light of New Legislation: Written Description, Enablement, the Doctrine of Equivalents and More."

For more information or to register for this event, please visit http://www.americanconference.com/fob.htm.
 

View as PDF